Ardea Biosciences' Acquisition

Ardea Biosciences was acquired by AstraZeneca on April 23, 2012.

Ardea Biosciences is focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). In March 2000, Ardea Biosciences went public…

Articles about Ardea Biosciences' Acquisition: